Incidental findings in lung cancer screening: What to report? (recorded 2026)

Speakers: Roberta Ledda, Parma/IT

Learning Objectives:
After watching the webinar, participants will be able to:
- have gained insight in the rationale of comorbidities and incidental findings of detected on low dose CT in LDCT-based LCS
- have learnt about the clinical significance of cardiovascular and respiratory obstructive airway diseases for mortality in the LCS population (“and the Big 3 approach”)
- have consolidated their knowledge about which incidental findings as should be reported and which should not being actionable, reportable and not-reportable
- be aware of the current statements recommendations and guidance on reporting and management of comorbidities and important incidental findings in LCSs